EUVIMEDEUVIMED entdecken
Crossref

The Haemato‐Oncology Frailty ( HOF ) score to assess frailty in lymphoma

Hena Ramdany iD, Thomas Lofaro iD, Simona Deplano

European Journal of Haematology · 2024-04 · 112 (4) · 611-620

DOI: 10.1111/ejh.14152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, online erschienen am 19.12.2023. Verfasst von Hena Ramdany und 2 weiteren Autor:innen. Beteiligte Einrichtung: Imperial College London, Isle of Wight NHS Trust, Newport, UK. Hauptthemen laut MEDLINE: Frailty, Multiple Myeloma, Lymphoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Morbidity and mortality during chemotherapy in older adults with haematological malignancy can be unpredictable. The Haemato‐Oncology Frailty (HOF) score was previously found to predict outcomes in a cohort of patients with plasma cell myeloma. In this study, we assess its utility in assessing frailty in patients with lymphoma, and compare its performance to that of two other frailty scores. The HOF score was able to predict progression‐free survival in this population, and was also shown to have potential in assessing the dynamism of frailty during chemotherapy. It performed well when compared to the Charlson Comorbidity Index (CCI) score and the Haematopoietic Cell Transplantation‐Specific Comorbidity Index (HCTCI), although the study was not powered to assess for non‐inferiority. The HOF score is a new score with the potential for application in different haematological malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyMultiple MyelomaLymphomaHumansAgedFrail ElderlyGeriatric Assessment

Stichwörter der Autor:innen

chemotherapyfrail elderlygeriatric assessmentlymphomaolder adultspersonalised medicinequality of life

Autor:innen und Institutionen

  • Imperial College London, Isle of Wight NHS Trust, Newport, UK.
  • Imperial College Healthcare NHS Trust, London, UK.

ORCID-Profile: Hena Ramdany, Thomas Lofaro

Zitieren

APA

Ramdany, H., Lofaro, T., & Deplano, S. (2024). The Haemato‐Oncology Frailty ( HOF ) score to assess frailty in lymphoma. European Journal of Haematology, 112(4), 611-620. https://doi.org/10.1111/ejh.14152

Vancouver

Ramdany H, Lofaro T, Deplano S. The Haemato‐Oncology Frailty ( HOF ) score to assess frailty in lymphoma. European Journal of Haematology. 2024;112(4):611-620. doi:10.1111/ejh.14152

BibTeX
@article{Ramdany2024,
  author = {Ramdany, Hena and Lofaro, Thomas and Deplano, Simona},
  title = {The Haemato‐Oncology Frailty ( HOF ) score to assess frailty in lymphoma},
  journal = {European Journal of Haematology},
  year = {2024},
  volume = {112},
  number = {4},
  pages = {611--620},
  doi = {10.1111/ejh.14152}
}
Kostenlos starten →